MERS-CoV: Understanding the latest human coronavirus threat
Loading...
Date
2018
Journal Title
Journal ISSN
Volume Title
Publisher
MDPI
Abstract
Human coronaviruses cause both upper and lower respiratory tract infections in humans.
In 2012, a sixth human coronavirus (hCoV) was isolated from a patient presenting with severe
respiratory illness. The 60-year-old man died as a result of renal and respiratory failure after admission
to a hospital in Jeddah, Saudi Arabia. The aetiological agent was eventually identified as a coronavirus
and designated Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV has now
been reported in more than 27 countries across the Middle East, Europe, North Africa and Asia.
As of July 2017, 2040 MERS-CoV laboratory confirmed cases, resulting in 712 deaths, were reported
globally, with a majority of these cases from the Arabian Peninsula. This review summarises the
current understanding of MERS-CoV, with special reference to the (i) genome structure; (ii) clinical
features; (iii) diagnosis of infection; and (iv) treatment and vaccine development.
Description
Keywords
Human coronavirus, MERS-CoV, Clinical features, Upper respiratory tract infections, Lower respiratory tract infections, Respiratory viruses
Citation
Chafekar, A. & Fielding, B.C. (2018). MERS-CoV: Understanding the latest human coronavirus threat. Viruses, 10(93)